Surprisingly, they found that due to a tumor protection mechanism controlled by BRD4 (Bromodomain-containing protein 4), cells from HGPS patients typically do not develop cancer. This evidence concerns the gene BRD4 and Hutchinson-Gilford progeria syndrome.